1. Didembourg, M., Locquet, M., Raskin, L., Tchimchoua, B. T., Dogné, J. M., Beaudart, C., & Douxfils, J. (2025). Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database. Contraception, 142, 110727.
  2. Quaas, P. Estetrol (E4) in Kontrazeption und Menopause – die Zukunft der weiblichen Hormontherapie (WHT)?. J. Gynäkol. Endokrinol. CH 29, 55–61 (2026).
  3. Al-Hendy, A., Lukes, A. S., Poindexter, A. N., 3rd, Venturella, R., Villarroel, C., Critchley, H. O., Li, Y., McKain, L., Arjona Ferreira, J. C., Langenberg, A. G., Wagman, R. B., & Stewart, E. A. (2023). A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies. Pain management, 13(4), 205–211.
  4. Muzii, L., Galati, G., Mercurio, A., Olivieri, C., Scarcella, L., Azenkoud, I., Tripodi, R., Vignali, M., Angioni, S., & Maiorana, A. (2024). Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study. Scientific reports, 14(1), 22481.
  5. Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., Saridogan, E., Tomassetti, C., van Hanegem, N., Vulliemoz, N., Vermeulen, N., & ESHRE Endometriosis Guideline Group (2022). ESHRE guideline: endometriosis. Human reproduction open, 2022(2), hoac009.
  6. La Marca, A., Semprini, M., Mastellari, E., Donno, V., Capuzzo, M., Alboni, C., & Giulini, S. (2025). Fertility preservation in women with endometriosis. Human reproduction open, 2025(2), hoaf012.
  7. Giudice, L. C., As-Sanie, S., Arjona Ferreira, J. C., Becker, C. M., Abrao, M. S., Lessey, B. A., Brown, E., Dynowski, K., Wilk, K., Li, Y., Mathur, V., Warsi, Q. A., Wagman, R. B., & Johnson, N. P. (2022). Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet (London, England), 399(10343), 2267–2279.
  8. Becker, C. M., Johnson, N. P., As-Sanie, S., Arjona Ferreira, J. C., Abrao, M. S., Wilk, K., Imm, S. J., Mathur, V., Perry, J. S., Wagman, R. B., & Giudice, L. C. (2024). Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study. Human reproduction (Oxford, England), 39(3), 526–537.
  9. Cihan, H., Bischofberger-Baumann, B., Bucher, J., Caironi, V., Claude, F., Del Vento, F., Egloff, M., Flütsch, N., Garcia Nuñez, D., Gobrecht-Keller, U., Iten, U., Jacot-Guillarmod, M., Kliebhan, J., Masciocchi, M., Mavromati, M., Meier, C., Papadakis, G., Rieben, C., Slahor, L., Soldati, L., … Winzeler, B. (2026). Endocrine care of transgender and gender-diverse adults: Swiss recommendations. Swiss medical weekly, 156, 5059.
  10. Schmidt-Beuchat, E. (2025). Clinical guidance and recommendations for in-office management of the neovagina: A review. International Journal of Reconstructive Urology, 3(2), 149–156.
  11. Polo-Kantola, P., Lindeberg, M., & Hirschberg, A. L. (2026). Transdermal estradiol spray in Nordic menopausal women: real-world patient outcomes. Climacteric : the journal of the International Menopause Society, 29(4), 551–557.
  12. Ferrari, S., Lippuner, K., Lamy, O., & Meier, C. (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss medical weekly, 150, w20352.
  13. https://www.fraxplus.org/de/calculation-tool
  14. Fettweis, J. M., Serrano, M. G., Brooks, J. P., Edwards, D. J., Girerd, P. H., Parikh, H. I., Huang, B., Arodz, T. J., Edupuganti, L., Glascock, A. L., Xu, J., Jimenez, N. R., Vivadelli, S. C., Fong, S. S., Sheth, N. U., Jean, S., Lee, V., Bokhari, Y. A., Lara, A. M., Mistry, S. D., … Buck, G. A. (2019). The vaginal microbiome and preterm birth. Nature medicine, 25(6), 1012–1021.
  15. Salem, Y., Oestreich, M. A., Fuchs, O., Usemann, J., Frey, U., Surbek, D., Amylidi-Mohr, S., Latzin, P., Ramsey, K., Yammine, S., & Bern Basel Infant Lung Development Study Group (2022). Are children born by cesarean delivery at higher risk for respiratory sequelae?. American journal of obstetrics and gynecology, 226(2), 257.e1–257.e11.
  16. Sinha, T., Brushett, S., Fernández-Pato, A., Garmaeva, S., Andreu-Sánchez, S., Spreckels, J. E., Mallon, C. A., Kuzub, N., Gois, M. B., Wu, J., Kruk, M., Jankipersadsing, S. A., Dekens, J. A. M., Gacesa, R., Vila, A. V., Bang, C., Perenboom, C., Franke, A., Tytgat, H. L. P., Mottaz, S. C., … Zhernakova, A. (2026). Maternal influences on infant gut microbiome and health. Nature, 10.1038/s41586-026-10922-9.
  17. https://www.gedeonrichter.com/en/about/history